Azenta (AZTA)

• Market cap: $2.3B
• 1 day: 1.88%
• 5 days: 12.47%
• 1 month: 12.95%
• 3 months: 2.35%
• 6 months: -11.11%
• Year to date: -22.25%
• 1 year: -19.36%
• 5 years: 18.85%
• 10 years: 298.34%
• Sector: Industrials
• Industry: Special Industry Machinery

About: Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Employees: 3,300

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.94% less ownership

Funds ownership: 101.37% [Q2] → 100.43% (-0.94%) [Q3]

3% less funds holding

Funds holding: 317 [Q2] → 306 (-11) [Q3]

17% less capital invested

Capital invested by funds: $2.88B [Q2] → $2.38B (-$496M) [Q3]

20% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 55

32% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 130

50% less funds holding in top 10

Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]

53% less call options, than puts

Call options by funds: $9.45M | Put options by funds: $20.1M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $50 1% downside
• Avg. target: $55 9% upside
• High target: $60 19% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Stephens & Co. Jacob Johnson 47% 1-year accuracy 8 / 17 met price target	19% upside $60	Overweight Upgraded	18 Dec 2024
Needham David Saxon 25% 1-year accuracy 15 / 61 met price target	9% upside $55	Buy Maintained	13 Nov 2024
Evercore ISI Group Vijay Kumar 60% 1-year accuracy 28 / 47 met price target	1% downside $50	In-Line Maintained	1 Oct 2024